Computational methods to detect EGFR mutations that can be deployed with little cost, rapid TAT and automated implementation while preserving tissue for comprehensive genomic sequencing have the potential to greatly improve the clinical workflow for lung cancer diagnostic biopsies. Here, EGFR is linked to lung cancer.